CrisPRO Blog
Insights, news, and research at the intersection of AI and oncology.
Featured Article
A Fusion AI Framework for Accelerated Therapeutic Design: An In-Silico Research-Use-Only Doctrine
95.7% AUROC ClinVar validation
July 28, 2025
The DeSci Front & Our Asymmetric Economic Engine
To establish and dominate a new, parallel economic system for funding therapeutic R&D
July 18, 2025
Mechanisms of Cancer Immunity and Cancer-related Autoimmunity - Abstract Submission
From automated variant interpretation to in silico therapeutic validation
July 08, 2025
Case Study in Action: Predicting Radiotherapy Response with TP53
Why do some patients respond well to radiation therapy, while others don't?
July 02, 2025
RFA: Leukemia Exploration and Prevention Grant Program (LEAP)
RUNX1-FPD Mechanistic Analysis
June 28, 2025
Pillar 6: The Triumvirate Checkpoint
Seventh pillar of CrisPRO platform, a testament to our commitment to reliability.
June 28, 2025
Operational Directive: Annihilation of Cancer of Unknown Primary (CUP)
Cancer of unknown primary (CUP) means that cancer spread has been found in your body (secondary cancer), but your doctors can't find where the cancer started.
June 26, 2025
Metastasis Isn't Fate. It's a Kill Chain. And We've Cracked the Code.
Metastasis is what kills. It's responsible for an estimatedĀ 90% of all cancer-related deaths
December 04, 2024
Introducing the CrisPRO Oncology Co-Pilot
Our mission to empower clinicians with smarter tools, to accelerate the discovery and development of life-saving therapies for researchers, and to offer patients a more personalized, connected, and hopeful journey.